18287258

Source:http://linkedlifedata.com/resource/pubmed/id/18287258

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0024143, umls-concept:C0034656, umls-concept:C0600558, umls-concept:C2587213, umls-concept:C2698651
pubmed:issue	3
pubmed:dateCreated	2008-4-28
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101271570
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1555-905X
pubmed:author	pubmed-author:ClarkWilliam FWF, pubmed-author:SontropJessica MJM
pubmed:issnType	Electronic
pubmed:volume	3
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	895-8
pubmed:meshHeading	pubmed-meshheading:18287258-Drug Therapy, Combination, pubmed-meshheading:18287258-Evidence-Based Medicine, pubmed-meshheading:18287258-Humans, pubmed-meshheading:18287258-Immunosuppressive Agents, pubmed-meshheading:18287258-Lupus Nephritis, pubmed-meshheading:18287258-Practice Guidelines as Topic, pubmed-meshheading:18287258-Randomized Controlled Trials as Topic, pubmed-meshheading:18287258-Research Design, pubmed-meshheading:18287258-Severity of Illness Index, pubmed-meshheading:18287258-Treatment Outcome
pubmed:year	2008
pubmed:articleTitle	What have we learned about optimal induction therapy for lupus nephritis (III through V) from randomized, controlled trials?
pubmed:affiliation	London Health Sciences Centre, and Department of Medicine, University of Western Ontario, London, Canada, N6A 4G5. william.clark@lhsc.on.ca
pubmed:publicationType	Journal Article